Published in Curr Cardiol Rev on November 01, 2010
Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Fail Rev (2014) 0.95
Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis. Biomed Res Int (2015) 0.85
One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat. ACS Chem Neurosci (2012) 0.84
The effect of chronic administration of safranal on systolic blood pressure in rats. Iran J Pharm Res (2015) 0.83
Antihypertensive effect of celery seed on rat blood pressure in chronic administration. J Med Food (2013) 0.82
Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation. Hypertension (2014) 0.80
Quantifying inter-species differences in contractile function through biophysical modelling. J Physiol (2015) 0.79
Sustained elevation of NF-κB activity sensitizes offspring of maternal inflammation to hypertension via impairing PGC-1α recovery. Sci Rep (2016) 0.76
Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats. Mol Cell Biochem (2013) 0.76
Identification of free nitric oxide radicals in rat bone marrow: implications for progenitor cell mobilization in hypertension. PLoS One (2013) 0.76
Neuropathy optic glaucomatosa induced by systemic hypertension through activation endothelin-1 signaling pathway in central retinal artery in rats. Int J Ophthalmol (2016) 0.75
Animal models for the study of primary and secondary hypertension in humans. Biomed Rep (2016) 0.75
Spontaneous one-kidney rats are more susceptible to develop hypertension by DOCA-NaCl and subsequent kidney injury compared with uninephrectomized rats. Am J Physiol Renal Physiol (2016) 0.75
Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models. Physiol Genomics (2017) 0.75
Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension. Hypertension (2016) 0.75
Points of control in inflammation. Nature (2002) 10.61
Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride. Can Med Assoc J (1943) 9.50
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol (2004) 3.27
The current epidemic of primary aldosteronism: causes and consequences. J Hypertens (2004) 2.83
Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol (2001) 2.72
Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension (2006) 2.59
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med (1992) 2.54
Aldosterone-induced inflammation in the rat heart : role of oxidative stress. Am J Pathol (2002) 2.33
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol (2005) 2.25
Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol (2007) 2.25
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation (1998) 1.90
Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res (2008) 1.88
Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation (2000) 1.87
Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol (2010) 1.87
Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal (2009) 1.80
Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J Hypertens (2004) 1.79
Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res (1998) 1.76
NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension (2001) 1.74
TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.73
NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther (2008) 1.58
Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertens (2004) 1.54
Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest (1994) 1.48
Differential regulation of NADPH oxidase in sympathetic and sensory Ganglia in deoxycorticosterone acetate salt hypertension. Hypertension (2007) 1.47
Histone deacetylase inhibitors in inflammatory disease. Curr Top Med Chem (2009) 1.46
Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats. J Hypertens (2002) 1.42
Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension (2001) 1.41
Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. Cell Biochem Biophys (2007) 1.38
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res (1975) 1.27
Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res (2004) 1.25
ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension (2003) 1.20
Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology (2007) 1.18
Catecholamine metabolism in experimental hypertension in the rat. Circ Res (1967) 1.17
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Br J Pharmacol (2010) 1.16
Redox signalling involving NADPH oxidase-derived reactive oxygen species. Biochem Soc Trans (2006) 1.14
Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2008) 1.08
Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension (2002) 1.07
Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension (1994) 1.07
Aldosterone and arterial hypertension. Nat Rev Endocrinol (2009) 1.06
Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats. Hypertension (2004) 1.04
Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun (2002) 1.02
Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats. J Cardiovasc Pharmacol (2007) 1.02
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Circulation (2001) 1.02
Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension (1993) 0.99
Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. J Am Soc Nephrol (1999) 0.99
NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension (2003) 0.98
The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Methods (1992) 0.98
The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem (2010) 0.97
Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol (2008) 0.96
l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2005) 0.96
NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. J Mol Cell Cardiol (2007) 0.95
Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension (1994) 0.95
The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. J Card Fail (2006) 0.93
Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Nephrol Dial Transplant (2008) 0.92
Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol (1992) 0.90
Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur J Pharmacol (2001) 0.90
A role for benzamil-sensitive proteins of the central nervous system in the pathogenesis of salt-dependent hypertension. Clin Exp Pharmacol Physiol (2008) 0.90
The nitrite/collagen reaction: non-enzymatic nitration as a model system for age-related damage. Connect Tissue Res (2001) 0.89
Dietary sesamin suppresses aortic NADPH oxidase in DOCA salt hypertensive rats. Clin Exp Pharmacol Physiol (2007) 0.89
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats. Br J Pharmacol (2002) 0.89
Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats. Hypertens Res (2010) 0.87
Selenium and antioxidant defenses as major mediators in the development of chronic heart failure. Heart Fail Rev (2006) 0.87
Wound healing following myocardial infarction. Clin Cardiol (1996) 0.87
Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats. Evid Based Complement Alternat Med (2011) 0.86
Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage. Clin Exp Hypertens (2010) 0.86
L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. Basic Clin Pharmacol Toxicol (2009) 0.86
Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension. Endocrinology (2002) 0.85
Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration. Endocrinology (2001) 0.85
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res (1996) 0.84
In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens (1995) 0.84
Alterations in sympathetic neuroeffector transmission to mesenteric arteries but not veins in DOCA-salt hypertension. Auton Neurosci (2009) 0.83
Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol (2006) 0.82
Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. Br J Pharmacol (2006) 0.82
Reversal of cardiac dysfunction by selective ET-A receptor antagonism. Br J Pharmacol (2005) 0.81
Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats. Gen Pharmacol (2000) 0.81
Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat. Clin Exp Hypertens (2006) 0.80
Cardiac allograft vasculopathy in heart transplant patients: pathologic and clinical aspects for angioplasty/stenting. J Am Coll Cardiol (2006) 0.80
Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension. J Hypertens (2009) 0.79
Cardioreparation and the concept of modulating cardiovascular structure and function. Blood Press (1993) 0.79
Interrelationships of sodium intake, hypertension, and norepinephrine storage in the rat. Circ Res (1969) 0.78
Counteraction of adriamycin-induced oxidative damage in rat heart by selenium dietary supplementation. J Agric Food Chem (2006) 0.77
Increased calcium influx mediates increased cardiac stiffness in hyperthyroid rats. Cell Biochem Biophys (2005) 0.76
Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens (2001) 0.76
Is mycophenolate more than just an immunosuppressant?--An overview. Indian J Biochem Biophys (2009) 0.76
Deveolpment of hypertension in rats maintained on a sodium deficient diet and bearing a mammotropic tumor (MtTF4). Virchows Arch B Cell Pathol (1975) 0.76
Ultrasound-guided popliteal block through a common paraneural sheath versus conventional injection: a prospective, randomized, double-blind study. Reg Anesth Pain Med (2013) 3.37
Hand motion analysis using the imperial college surgical assessment device: validation of a novel and objective performance measure in ultrasound-guided peripheral nerve blockade. Reg Anesth Pain Med (2011) 2.87
Defining adductor canal block. Reg Anesth Pain Med (2014) 2.48
Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination. Anesth Analg (2013) 2.14
Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block: a randomized, triple-arm, double-blind, placebo-controlled trial. Reg Anesth Pain Med (2015) 2.07
Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol (2010) 1.87
The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg (2007) 1.64
The sensitivity of motor response to nerve stimulation and paresthesia for nerve localization as evaluated by ultrasound. Reg Anesth Pain Med (2006) 1.63
Redefining the adductor canal block. Reg Anesth Pain Med (2014) 1.61
Enlargement of the small aortic root during aortic valve replacement: is there a benefit? Ann Thorac Surg (2008) 1.60
Intraspinal techniques for pain management in cancer patients: a systematic review. Support Care Cancer (2010) 1.54
The Optimal Analgesic Block for Total Knee Arthroplasty. Reg Anesth Pain Med (2016) 1.53
Caffeine attenuates metabolic syndrome in diet-induced obese rats. Nutrition (2012) 1.53
Identification of sister chromatids by DNA template strand sequences. Nature (2009) 1.53
Rodent models for metabolic syndrome research. J Biomed Biotechnol (2010) 1.53
Ultrasound-guided popliteal block distal to sciatic nerve bifurcation shortens onset time: a prospective randomized double-blind study. Reg Anesth Pain Med (2010) 1.51
Refining the ultrasound-guided interscalene brachial plexus block: the superior trunk approach. Can J Anaesth (2014) 1.49
Degenerate peptide recognition by Candida albicans adhesins Als5p and Als1p. Infect Immun (2004) 1.47
Anomalous brachial plexus anatomy in the supraclavicular region detected by ultrasound. Anesth Analg (2008) 1.41
Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res (2011) 1.39
Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. Cell Biochem Biophys (2007) 1.38
Practical considerations in preparing the pig carcass spine phantom. Reg Anesth Pain Med (2010) 1.38
Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation (2007) 1.33
High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol (2011) 1.31
Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr (2010) 1.23
Ultrasound imaging of peripheral nerves: a need for a new trend. Reg Anesth Pain Med (2005) 1.17
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Br J Pharmacol (2010) 1.16
Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J Nutr (2011) 1.14
Basic Topography of the Saphenous Nerve in the Femoral Triangle and the Adductor Canal. Reg Anesth Pain Med (2015) 1.12
Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr (2012) 1.10
Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma. Int J Gynecol Pathol (2005) 1.10
Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res (2011) 1.09
Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur J Nutr (2012) 1.07
Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ (2002) 1.05
The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ (2003) 1.05
Ultrasound imaging facilitates spinal anesthesia in adults with difficult surface anatomic landmarks. Anesthesiology (2011) 1.04
Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats. J Cardiovasc Pharmacol (2013) 1.04
Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation (2005) 1.04
Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY. J Natl Cancer Inst (2005) 1.03
Single-injection or continuous femoral nerve block for total knee arthroplasty? Clin Orthop Relat Res (2014) 1.03
Ultrasound in regional anesthesia: where should the "focus" be set? Reg Anesth Pain Med (2009) 1.02
Lower-extremity peripheral nerve blockade: essentials of our current understanding. Reg Anesth Pain Med (2005) 1.02
Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients (2013) 1.01
Chronic high-carbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiol Endocrinol Metab (2012) 1.00
Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Curr Pharm Biotechnol (2011) 1.00
Potential health benefits of Indian spices in the symptoms of the metabolic syndrome: a review. Indian J Biochem Biophys (2009) 0.98
Lysine acetylation in obesity, diabetes and metabolic disease. Immunol Cell Biol (2011) 0.98
Cardiac extracellular matrix: a dynamic entity. Am J Physiol Heart Circ Physiol (2005) 0.98
Antibody targeting of B-cell maturation antigen on malignant plasma cells. Mol Cancer Ther (2007) 0.98
Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem (2012) 0.98
C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J (2012) 0.97
Rac1 GTPase is activated by hepatitis B virus replication--involvement of HBX. Biochim Biophys Acta (2007) 0.97
Label-free intracellular transport measured by spatial light interference microscopy. J Biomed Opt (2011) 0.97
Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a case-matched study. Eur J Cardiothorac Surg (2011) 0.97
The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem (2010) 0.97
l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2005) 0.96
Ultrasonography as a preoperative assessment tool: predicting the feasibility of central neuraxial blockade. Anesth Analg (2009) 0.95
Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interact Cardiovasc Thorac Surg (2010) 0.95
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats. J Immunol (2006) 0.95
Ultrasound-guided peripheral nerve blockade. Curr Opin Anaesthesiol (2008) 0.94
Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. Am J Physiol Heart Circ Physiol (2006) 0.93
Correlates of putting condoms on after sex has begun and of removing them before sex ends: a study of men attending an urban public STD clinic. Am J Mens Health (2007) 0.93
Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr (2012) 0.93
Lipid redistribution by α-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J Nutr Biochem (2011) 0.93
The HBSP gene is expressed during HBV replication, and its coded BH3-containing spliced viral protein induces apoptosis in HepG2 cells. Biochem Biophys Res Commun (2006) 0.92
Comparison of purple carrot juice and β-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr (2010) 0.92
Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. FASEB J (2013) 0.92
High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol (2011) 0.92
Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial. J Thorac Cardiovasc Surg (2008) 0.91
Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. Nutrients (2012) 0.91
"Living" microvascular stamp for patterning of functional neovessels; orchestrated control of matrix property and geometry. Adv Mater (2011) 0.91
An ultrasound-assisted approach facilitates spinal anesthesia for total joint arthroplasty. Can J Anaesth (2009) 0.91
The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol Clin Exp Res (2009) 0.90
An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats. Diabetes (2012) 0.90
Three-dimensional microchannels in biodegradable polymeric films for control orientation and phenotype of vascular smooth muscle cells. Tissue Eng (2006) 0.89
Off-pump coronary artery bypass grafting does not preserve renal function better than on-pump coronary artery bypass grafting: results of a case-matched study. J Thorac Cardiovasc Surg (2011) 0.89
Intra- and interrater reliability of ultrasound assessment of gastric volume. Anesthesiology (2014) 0.89
The influence of GFP-actin expression on the adhesion dynamics of HepG2 cells on a model extracellular matrix. Biomaterials (2005) 0.89
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats. Br J Pharmacol (2002) 0.89
A co-occurrence of osteogenesis imperfecta type VI and cystinosis. Am J Med Genet A (2012) 0.88
Cardiomyocyte imaging using real-time spatial light interference microscopy (SLIM). PLoS One (2013) 0.88
Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol (2011) 0.88
The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats. Transpl Int (2012) 0.86
L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. Basic Clin Pharmacol Toxicol (2009) 0.86
Characterization of mitral valve prolapse with cardiac computed tomography: comparison to echocardiographic and intraoperative findings. Int J Cardiovasc Imaging (2011) 0.86
Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats. Evid Based Complement Alternat Med (2011) 0.86
Anesthesia for carpal tunnel release. Can J Anaesth (2003) 0.86
Effects of red pitaya juice supplementation on cardiovascular and hepatic changes in high-carbohydrate, high-fat diet-induced metabolic syndrome rats. BMC Complement Altern Med (2014) 0.85
Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestine. Clin Exp Pharmacol Physiol (2002) 0.85
Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital. Dig Dis Sci (2011) 0.85
Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy. Expert Opin Drug Saf (2009) 0.85
Label-free imaging of cell attachment with photonic crystal enhanced microscopy. Analyst (2011) 0.84
Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PLoS One (2013) 0.84
Dynamics of smooth muscle cell deadhesion from thermosensitive hydroxybutyl chitosan. Biomaterials (2006) 0.84
Evaluation of the chronic complications of diabetes in a high fructose diet in rats. Indian J Biochem Biophys (2009) 0.84
Gender differences in metabolic syndrome: a key research issue? Endocr Metab Immune Disord Drug Targets (2011) 0.83
Ultrasound-guided cervical periradicular steroid injection for cervical radicular pain: relevance of spread pattern and degree of penetration of contrast medium. Pain Med (2012) 0.83
Objective assessment of manual skills and proficiency in performing epidural anesthesia--video-assisted validation. Reg Anesth Pain Med (2006) 0.83